The California Stem Cell Report

Share this post

User's avatar
The California Stem Cell Report
CIRM's 'Adventure with a Deadline:' How Billions will be Spent Pursuing Stem Cell and Gene Therapies

CIRM's 'Adventure with a Deadline:' How Billions will be Spent Pursuing Stem Cell and Gene Therapies

California refocusing spending priorities, dollars likely to go in different directions

David Jensen's avatar
David Jensen
Mar 26, 2024
∙ Paid

Share this post

User's avatar
The California Stem Cell Report
CIRM's 'Adventure with a Deadline:' How Billions will be Spent Pursuing Stem Cell and Gene Therapies
Share
CIRM’s timetable for devising its new framework for funding priorities. SAF stands for Strategic Allocation Framework. ICOC is the abbreviation for the CIRM board’s name.

For patients, researchers and policymakers, the next three days mark the beginning of a key, new “adventure” in the gene and stem cell therapy world of the $12 billion California Instit…

Keep reading with a 7-day free trial

Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 David Jensen
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share